SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General Statement of Acquisition of Beneficial Ownership:
SEC Accession No. 0000950134-06-002651
Filing Date
2006-02-13
Accepted
2006-02-13 17:08:02
Documents
1
Group Members
MPM ASSET MANAGEMENT INVESTORS 2005 BVIII LLCMPM BIOVENTURES III GMBH & CO BETEILIGUNGS KGMPM BIOVENTURES III GP LPMPM BIOVENTURES III LLCMPM BIOVENTURES III PARALLEL FUND LPMPM BIOVENTURES III QP LP

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13D f17367sc13d.htm SC 13D 175244
  Complete submission text file 0000950134-06-002651.txt   177628
Mailing Address 300 ELLIOTT AVENUE WEST SUITE 500 SEATTLE WA 98119-4114
Business Address 300 ELLIOTT AVENUE WEST SUITE 500 SEATTLE WA 98119-4114 2062817001
NEORX CORP (Subject) CIK: 0000755806 (see all company filings)

IRS No.: 911261311 | State of Incorp.: WA | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-40119 | Film No.: 06604654
SIC: 2835 In Vitro & In Vivo Diagnostic Substances

Mailing Address THE JOHN HANCOCK TOWER 200 CLARENDON STREET, 5TH FLOOR BOSTON MA 02116
Business Address THE JOHN HANCOCK TOWER 200 CLARENDON STREET, 5TH FLOOR BOSTON MA 02116 617 425 9200
MPM BIOVENTURES III LP (Filed by) CIK: 0001173408 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D